Ginkgolide B reduces neuronal cell apoptosis in the traumatic rat brain: Possible involvement of toll-like receptor 4 and nuclear factor kappa B pathway

Phytotherapy Research

Volumn 26, Issue 12, 2012, Pages 1838-1844

  Yu, Wen Hua ^a   Dong, Xiao Qiao ^a   Hu, Yue Yu ^b   Huang, Man ^b   Zhang, Zu Yong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

ginkgolide B; inflammatory cytokine; neuronal cell apoptosis; nuclear factor B; toll like receptor 4; traumatic brain injury

Indexed keywords

GINKGOLIDE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN LEVEL; BRAIN NERVE CELL; BRAIN TISSUE; CELL COUNT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG INHIBITION; DRUG MECHANISM; INFLAMMATION; INTRACELLULAR SIGNALING; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; RAT; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; BRAIN; BRAIN INJURIES; GINKGOLIDES; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LACTONES; MALE; NEURONS; NF-KAPPA B; RATS; TOLL-LIKE RECEPTOR 4;

RATTUS; RATTUS NORVEGICUS;

EID: 84871323716     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4662     Document Type: Article

References (58)

1. Aderem A, Ulevitch RJ,. 2000. Toll-like receptors in the induction of the innate immune response. Nature 6797: 782-787.
2. Akiba S, Kawauchi T, Oka T, et al,. 1998. Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. Biochem Mol Biol Int 46: 1243-1248.
3. Akira S, Takeda K, Kaisho T,. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-680.
4. Anderson KV,. 2000. Toll signaling pathways in the innate immune response. Curr Opin Immunol 12: 13-19.
5. Andrieu S, Ousset PJ, Coley N, et al,. 2008. GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. Rationale, design and baseline data. Curr alzheimer Res 5: 406-415.
6. Attella MJ, Hoffman SW, Stasio MJ, et al,. 1989. Ginkgo biloba extract facilitates recovery from penetrating brain injury in adult male rats. Exp Neurol 105: 62-71.
7. Ballabh P, Braun A, Nedergaard M,. 2004. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16: 1-13.
8. Bate C, Salmona M, Williams A,. 2004. Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42. J Neuroinflammation 1: 4.
9. Begley DJ, Brightman MW,. 2003. Structural and functional aspects of the blood-brain barrier. Prog Drugs Res 61: 39-78.
10. Bermpohl D, You Z, Lo EH, et al,. 2007. TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice. J Cereb Blood Flow Metab 27: 1806-1818.
11. Chen G, Shi J, Jin W, et al,. 2008. Progesterone administration modulates TLRs/NF-kappaB signaling pathway in rat brain after cortical contusion. Ann Clin Lab Sci 38: 65-74.
12. Clark WM, Rinker LG, Lessov NS, et al,. 2001. Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke 32: 1000-1004.
13. DeFeudis FV, Drieu K,. 2000. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 1: 25-58.
14. Desouza IA, Hyslop S, Franco-Penteado CF, et al,. 2002. Evidence for the involvement of a macrophage-derived chemotactic mediator in the neutrophil recruitment induced by Staphylococcal enterotoxin B in mice. Toxicon 40: 1709-17017.
15. Desquand S, Touvay C, Randon J, et al,. 1986. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig. Eur J Pharmacol 127: 83-95.
16. Dirnagl U, Iadecola C, Moskowitz MA,. 1999. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391-397.
17. Drieu K,. 1986. Preparation and definition of Ginkgo biloba extract. Presse Med 15: 1455-1457.
18. Fang W, Deng Y, Li Y, et al,. 2010. Blood-brain barrier permeability and therapeutic time window of ginkgolide B in ischemia-reperfusion injury. Eur J Pharm Sci 39: 8-14.
19. Feeney DM, Boyeson MG, Linn RT, et al,. 1981. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 211: 67-77.
20. Foldes-Filep E, Braquet P, Filep J,. 1987. Inhibition by BN52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes. Biochem Biophys Res Commun 148: 1412-1417.
21. Gaetz M,. 2004. The neurophysiology of brain injury. Clin Neurophysiol 115: 4-18.
22. Guidetti C, Paracchini S, Lucchini S, et al,. 2001. Prevention of neuronal cell damage induced by oxidative stress in-vitro: effect of different Ginkgo biloba extracts. J Pharm Pharmacol 53: 387-392.
23. Hang CH, Shi JX, Tian J, et al,. 2004. Effect of systemic LPS injection on cortical NF-kappaB activity and inflammatory response following traumatic brain injury in rats. Brain Res 1026: 23-32.
24. Hang CH, Chen G, Shi JX, et al,. 2006. Cortical expression of nuclear factor kappa B after human brain contusion. Brain Res 1109: 14-21.
25. Hotter G, Closa D, Prats N, et al,. 1997. Free radical enhancement promotes leucocyte recruitment through a PAF and LTB4 dependent mechanism. Free Radical Biol Med 22: 947-954.
26. Huang JY, Sun JN, Mei SC,. 2008. Protective effects of ginkgolide B on cerebral ischemia reperfusion injury in rats. Chin Pharm Bull 24: 269-272.
27. Ihl R, Tribanek M, Bachinskaya N,. 2010. Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial. J Neurol Sci 299: 184-187.
28. Kimura H, Wu NZ, Dodge R, et al,. 1995. Inhibition of radiation-induced up-regulation of leukocyte adhesion to endothelial cells with the platelet-activating factor inhibitor, BN52021. Int J Radiat Oncol Biol Phys 33: 627-633.
29. Kleijnen J, Knipschild P,. 1992. Ginkgo biloba. Lancet 340: 1136-1139.
30. Kurihara K, Wardlaw AJ, Moqbel R, et al,. 1989. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN52021. J Allergy Clin Immunol 83: 83-90.
31. Li R, Chen B, Wu W, et al,. 2009. Ginkgolide B suppresses intercellular adhesion molecule-1 expression via blocking nuclear factor-kappaB activation in human vascular endothelial cells stimulated by oxidized low-density lipoprotein. J Pharmacol Sci 110: 362-369.
32. Li SQ, Zhang Y, Yang LJ,. 2007. Improving effect of ginkgolide B on mitochondrial respiration of ischemic neuron after cerebral thrombosis in tree shrews. Chin Med J 120: 1529-1533.
33. Ling NS, Pi ZF, Du RH, et al,. 2002. Study on the antioxidative effect of ginkgolide B to the ischemia-reperfused rabbit. J Harbin Univ Comm Nature Sci Edn 18: 83-85.
34. Liu B, Zhang H, Li S, et al,. 1996. Effects of MTX and BN52021 on PAF-induced chemotaxis of PMNs and intraepidermal accumulation of inflammatory cells in guinea pigs. Chin Med J 109: 467-470.
35. Liu YG, Li FJ, Wang J, et al,. 2010. Effects of ginkgolide B on inflammation induced by cerebral ischemia-reperfusion in rats. Zhong Yao Cai 33: 578-580.
36. Lu J, Goh SJ, Tng PY, et al,. 2009. Systemic inflammatory response following acute traumatic brain injury. Front Biosci 14: 3795-3813.
37. Maclennan KM, Darlington CL, Smith PF,. 2002. The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol 67: 235-257.
38. Nie ZG, Peng SY, Wang WJ,. 2004. Effects of ginkgolide B on lipopolysaccharide-induced TNFalpha production in mouse peritoneal macrophages and NF-kappaB activation in rat pleural polymorphonuclear leukocytes. Yao Xue Xue Bao 39: 415-418.
39. Paul FS, Karyn M, Cynthia LD,. 1996. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol 50: 131-139.
40. Peng SY, Liao WH, Nie ZG, et al,. 2010. Effect of ginkgolide B on the production of NO, IL-6 and RANTES from astrocytes. Yao Xue Xue Bao 45: 1103-1108.
41. Pierre B, David H,. 1991. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. J Ethnopharmacol 32: 135-139.
42. Qin B, Zhang GB, Chen DY, et al,. 2005. Protective effects of ginkgolide B on neuron injury induced by cerebral ischemia/reperfusion. Chin J Integr Trad West Med Inten Crit Care 12: 17-20.
43. Raghupathi R, Graham DI, McIntosh TK,. 2000. Apoptosis after traumatic brain injury. J Neurotrauma 17: 927-938.
44. Schmidt H, Ebeling D, Bauer H, et al,. 1996. Influence of the platelet-activating factor receptor antagonist BN52021 on endotoxin-induced leukocyte adherence in rat mesenteric venules. J Surg Res 60: 29-35.
45. Van Dongen MC, van Rossum E, Kessels AG, et al,. 2000. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc 48: 1183-1194.
46. Van Dongen M, van Rossum E, Kessels A, et al,. 2003. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Clin Epidemiol 56: 367-376.
47. Vargaftig BB, Benveniste J,. 1983. Platelet-activating factor today. Trends Pharmacol Sci 4: 341-343.
48. Vargaftig BB, Lefort J, Chignard M, et al,. 1980. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol 65: 185-192.
49. Vellas B, Andrieu S, Ousset PJ, et al,. 2006. The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of alzheimer disease in patients over 70 with a memory complaint. Neurology 67: S6-11.
50. Wang JH, Sun GY,. 2000. Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC). Neurochem Res 25: 613-619.
51. Wong J, Hoe NW, Zhiwei F, et al,. 2005. Apoptosis and traumatic brain injury. Neurocrit Care 3: 177-182.
52. Wu X, Qian Z, Ke Y, et al,. 2009. Ginkgolide B preconditioning protects neurons against ischaemia-induced apoptosis. J Cell Mol Med 13: 4474-4483.
53. Xia SH, Fang DC,. 2007. Pharmacological action and mechanisms of ginkgolide B. Chin Med J 120: 922-928.
54. Xiao Q, Wang C, Li J, et al,. 2010. Ginkgolide B protects hippocampal neurons from apoptosis induced by beta-amyloid 25-35 partly via up-regulation of brain-derived neurotrophic factor. Eur J Pharmacol 647: 48-54.
55. Yang ZZ, Li J, Li SX, et al,. 2011. Effect of ginkgolide B on striatal extracellular amino acids in middle cerebral artery occluded rats. J Ethnopharmacol 136: 117-122.
56. Zhang S, Chen B, Wu W, et al,. 2011. Ginkgolide B reduces inflammatory protein expression in oxidized low-density lipoprotein-stimulated human vascular endothelial cells. J Cardiovasc Pharm 57: 721-727.
57. Zhang SF, Huang JY, Wang J, et al,. 2006. Effect of ginkgolide B injection on rat cerebral ischemia reperfusion lesion. J Beijing Univ Trad Chin Med 29: 836-839.
58. Zhou LE, Wang WJ, Bai JY, et al,. 2001. Effects of ginkgolide B on arachidonic acid metabolizing enzymes and level of intracellular calcium in rat polymorphonuclear leukocytes. Acta Pharmacol Sin (Chin) 36: 92-95.